Home / Tag Archives: Nephrology

Tag Archives: Nephrology

Not All Diabetic Kidney Disease Is the Same—Scientists Just Found a Hidden Subtype

Medical illustration showing a human kidney with an enlarged view of immune B-cell activity, representing a newly discovered diabetic kidney disease subtype associated with kidney inflammation.

For years, diabetic kidney disease (DKD) has been viewed as a single condition that progresses in a fairly predictable way. However, new research suggests that this assumption may overlook important biological differences between patients. Scientists have now identified a previously hidden subtype of diabetic kidney disease marked by increased B-cell …

Read More »

Farxiga Just Went Generic—Will Lower Prices Finally Change Diabetes Care?

Prescription bottle of generic dapagliflozin (Farxiga) beside a blood glucose meter, stethoscope, heart model, and kidney model representing diabetes, cardiovascular, and kidney care.

For many people living with type 2 diabetes, the biggest challenge is not finding an effective medication. It is being able to afford it. That reality may begin to change now that the U.S. Food and Drug Administration (FDA) has approved the first generic versions of Farxiga (dapagliflozin), potentially making …

Read More »

When Cardiology Meets Endocrinology: Why Diabetes Care Is Becoming a Team Sport

Multidisciplinary healthcare team including a cardiologist and endocrinologist collaborating on diabetes management with cardiovascular risk assessment in a modern clinical setting.

Not long ago, diabetes management focused primarily on controlling blood glucose levels. Today, that approach has evolved dramatically as cardiologists and endocrinologists increasingly work together to reduce cardiovascular risk. Thanks to groundbreaking cardiovascular outcome trials (CVOTs), clinicians now understand that treating type 2 diabetes means protecting the heart, kidneys, and …

Read More »

Beyond SGLT2 Inhibitors: Why Non-Steroidal MRAs Are Becoming the Third Pillar of Kidney Protection

Illustration of healthy kidneys with medication representing non-steroidal mineralocorticoid receptor antagonists alongside SGLT2 inhibitor therapy for diabetic kidney disease management.

For years, the treatment of diabetic kidney disease focused primarily on glycemic control and blood pressure management. More recently, SGLT2 inhibitors and GLP-1 receptor agonists have transformed the landscape by reducing kidney disease progression and cardiovascular events. However, another therapeutic class is rapidly gaining recognition. Non-steroidal mineralocorticoid receptor antagonists (MRAs) …

Read More »

Getting to 120 Safely: A Practical Guide to Intensive Blood Pressure Management in Diabetes

Healthcare professional monitoring blood pressure in a patient with diabetes using a digital blood pressure monitor, highlighting intensive blood pressure management and cardiovascular risk reduction.

Blood pressure control remains one of the most powerful tools for reducing cardiovascular and kidney complications in people with diabetes. While clinicians have traditionally focused on achieving targets below 140/90 mmHg, recent evidence and the 2026 American Diabetes Association Standards of Care support a more intensive approach for selected high-risk …

Read More »

When Diabetes Isn’t the Main Problem: Managing Comorbidities Without Losing Focus

Medical stethoscope, glucose meter, and a clipboard showing icons for heart, kidneys, and brain, symbolizing comorbidities in type 2 diabetes management.

Living with type 2 diabetes often means managing more than just blood glucose. For many patients, conditions like cardiovascular disease, chronic kidney disease, or depression take center stage in their care plan. When diabetes isn’t the main problem, how do you keep glucose control on track without compromising treatment for …

Read More »